本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNexus Gene Lab Corp.

6.43
-0.3900-5.72%
盘后6.16-0.2700-4.20%16:59 EDT
成交量:93.21万
成交额:655.60万
市值:1,155.21万
市盈率:-5.43
高:8.24
开:6.55
低:6.12
收:6.82
数据加载中...
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/06

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]